Kalshi to allow bets on clinical trials, FDA decisions

Kalshi platform will start accepting bets on clinical trials and FDA decisions. This was reported by Qazaqyia.kz citing Reuters.

The new feature will allow users to make predictions on clinical trial outcomes and FDA drug approval decisions. This move aims to expand prediction markets in the biotech sector.